Cholesterol modulates open probability and desensitization of NMDA receptors

Journal of Physiology

Volumn 593, Issue 10, 2015, Pages 2279-2293

  Korinek, Miloslav ^a   Vyklicky, Vojtech ^a   Borovska, Jirina ^a   Lichnerova, Katarina ^a,b   Kaniakova, Martina ^a   Krausova, Barbora ^a,b   Krusek, Jan ^a   Balik, Ales ^a   Smejkalova, Tereza ^a   Horak, Martin ^a   Vyklicky, Ladislav ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; CHOLEST 4 EN 3 ONE; CHOLESTEROL; CHOLESTEROL OXIDASE; KAINIC ACID RECEPTOR; METHYL BETA CYCLODEXTRIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SIMVASTATIN; BETA CYCLODEXTRIN DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; MEMBRANE LIPID; METHYL-BETA-CYCLODEXTRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE FLUIDITY; CEREBELLUM CELL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVITY; FEMALE; GRANULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROBABILITY; PROTEIN LIPID INTERACTION; RAT; ANIMAL; CELL CULTURE; CEREBELLUM; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; ELECTROPHYSIOLOGY; MEMBRANE FLUIDITY; NERVE CONDUCTION; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; SYNAPTIC TRANSMISSION; WISTAR RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BETA-CYCLODEXTRINS; CELLS, CULTURED; CEREBELLUM; CHOLESTEROL; CHOLESTEROL OXIDASE; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; MALE; MEMBRANE FLUIDITY; MEMBRANE LIPIDS; NEURAL CONDUCTION; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SIMVASTATIN; SYNAPTIC TRANSMISSION;

EID: 84929502927     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.288209     Document Type: Article

References (54)

1. Abulrob A, Tauskela JS, Mealing G, Brunette E, Faid K & Stanimirovic D (2005). Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution. J Neurochem 92, 1477-1486.
2. Borroni V, Baier CJ, Lang T, Bonini I, White MM, Garbus I & Barrantes FJ (2007). Cholesterol depletion activates rapid internalization of submicron-sized acetylcholine receptor domains at the cell membrane. Mol Membr Biol 24, 1-15.
3. Bosel J, Gandor F, Harms C, Synowitz M, Harms U, Djoufack PC, Megow D, Dirnagl U, Hortnagl H, Fink KB & Endres M (2005). Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J Neurochem 92, 1386-1398.
4. Brannigan G, Henin J, Law R, Eckenhoff R & Klein ML (2008). Embedded cholesterol in the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 105, 14418-14423.
5. Bruses JL, Chauvet N & Rutishauser U (2001). Membrane lipid rafts are necessary for the maintenance of the (alpha)7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons. J Neurosci 21, 504-512.
6. Cais O, Sedlacek M, Horak M, Dittert I & Vyklicky L, Jr (2008). Temperature dependence of NR1/NR2B NMDA receptor channels. Neuroscience 151, 428-438.
7. Casado M & Ascher P (1998). Opposite modulation of NMDA receptors by lysophospholipids and arachidonic acid: common features with mechanosensitivity. J Physiol 513 (Pt 2), 317-330.
8. Cibickova L (2011). Statins and their influence on brain cholesterol. J Clin Lipidol 5, 373-379.
9. Clark BA, Farrant M & Cull-Candy SG (1997). A direct comparison of the single-channel properties of synaptic and extrasynaptic NMDA receptors. J Neurosci 17, 107-116.
10. Colquhoun D & Sakmann B (1985). Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate. J Physiol 369, 501-557.
11. +-ATPase in discrete microdomain clusters in rat cerebellar granule cells. Neurochem Int 46, 489-499.
12. Dietschy JM & Turley SD (2004). Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45, 1375-1397.
13. Distl R, Treiber-Held S, Albert F, Meske V, Harzer K & Ohm TG (2003). Cholesterol storage and tau pathology in Niemann-Pick type C disease in the brain. J Pathol 200, 104-111.
14. Endo A (2010). A historical perspective on the discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci 86, 484-493.
15. Erreger K, Dravid SM, Banke TG, Wyllie DJ & Traynelis SF (2005). Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol 563, 345-358.
16. Farrant M, Feldmeyer D, Takahashi T & Cull-Candy SG (1994). NMDA-receptor channel diversity in the developing cerebellum. Nature 368, 335-339.
17. Frank C, Giammarioli AM, Pepponi R, Fiorentini C & Rufini S (2004). Cholesterol perturbing agents inhibit NMDA-dependent calcium influx in rat hippocampal primary culture. FEBS Lett 566, 25-29.
18. Frank C, Rufini S, Tancredi V, Forcina R, Grossi D & D'Arcangelo G (2008). Cholesterol depletion inhibits synaptic transmission and synaptic plasticity in rat hippocampus. Exp Neurol 212, 407-414.
19. Gimpl G, Burger K & Fahrenholz F (1997). Cholesterol as modulator of receptor function. Biochemistry 36, 10959-10974.
20. Hering H, Lin CC & Sheng M (2003). Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 23, 3262-3271.
21. Horak M, Vlcek K, Petrovic M, Chodounska H & Vyklicky L, Jr (2004). Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors. J Neurosci 24, 10318-10325.
22. Christian AE, Haynes MP, Phillips MC & Rothblat GH (1997). Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res 38, 2264-2272.
23. Illinger D, Duportail G, Mely Y, Poirel-Morales N, Gerard D & Kuhry JG (1995). A comparison of the fluorescence properties of TMA-DPH as a probe for plasma membrane and for endocytic membrane. Biochimica et biophysica acta 1239, 58-66.
24. Jahr CE (1992). High probability opening of NMDA receptor channels by L-glutamate. Science 255, 470-472.
25. Korinek M, Sedlacek M, Cais O, Dittert I & Vyklicky L, Jr (2010). Temperature dependence of N-methyl-D-aspartate receptor channels and N-methyl-D-aspartate receptor excitatory postsynaptic currents. Neuroscience 165, 736-748.
26. Lester RA & Jahr CE (1992). NMDA channel behavior depends on agonist affinity. J Neurosci 12, 635-643.
27. Levitan I, Singh DK & Rosenhouse-Dantsker A (2014). Cholesterol binding to ion channels. Front Physiol 5, 65.
28. Liebisch G, Binder M, Schifferer R, Langmann T, Schulz B & Schmitz G (2006). High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Biochim Biophys Acta 1761, 121-128.
29. Lichnerova K, Kaniakova M, Skrenkova K, Vyklicky L & Horak M (2014). Distinct regions within the GluN2C subunit regulate the surface delivery of NMDA receptors. Front Cell Neurosci 8, 375.
30. Linsenbardt AJ, Taylor A, Emnett CM, Doherty JJ, Krishnan K, Covey DF, Paul SM, Zorumski CF & Mennerick S (2014). Different oxysterols have opposing actions at N-methyl-d-aspartate receptors. Neuropharmacology 85C, 232-242.
31. Luo JH, Fu ZY, Losi G, Kim BG, Prybylowski K, Vissel B & Vicini S (2002). Functional expression of distinct NMDA channel subunits tagged with green fluorescent protein in hippocampal neurons in culture. Neuropharmacology 42, 306-318.
32. Miller B, Sarantis M, Traynelis SF & Attwell D (1992). Potentiation of NMDA receptor currents by arachidonic acid. Nature 355, 722-725.
33. Ogden KK & Traynelis SF (2011). New advances in NMDA receptor pharmacology. Trends Pharmacol Sci 32, 726-733.
34. Ogden KK & Traynelis SF (2013). Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptors. Mol Pharmacol 83, 1045-1056.
35. Ohvo-Rekila H, Ramstedt B, Leppimaki P & Slotte JP (2002). Cholesterol interactions with phospholipids in membranes. Prog Lipid Res 41, 66-97.
36. Ottico E, Prinetti A, Prioni S, Giannotta C, Basso L, Chigorno V & Sonnino S (2003). Dynamics of membrane lipid domains in neuronal cells differentiated in culture. J Lipid Res 44, 2142-2151.
37. Ozaki M, Sasner M, Yano R, Lu HS & Buonanno A (1997). Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 390, 691-694.
38. Paila YD & Chattopadhyay A (2009). The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? Glycoconj J 26, 711-720.
39. Paul SM, Doherty JJ, Robichaud AJ, Belfort GM, Chow BY, Hammond RS, Crawford DC, Linsenbardt AJ, Shu HJ, Izumi Y, Mennerick SJ & Zorumski CF (2013). The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors. J Neurosci 33, 17290-17300.
40. Pike LJ, Han X, Chung KN & Gross RW (2002). Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry 41, 2075-2088.
41. Ponce J, dela Ossa NP, Hurtado O, Millan M, Arenillas JF, Davalos A & Gasull T (2008). Simvastatin reduces the association of NMDA receptors to lipid rafts: a cholesterol-mediated effect in neuroprotection. Stroke 39, 1269-1275.
42. Popescu G & Auerbach A (2003). Modal gating of NMDA receptors and the shape of their synaptic response. Nat Neurosci 6, 476-483.
43. Prybylowski K, Fu Z, Losi G, Hawkins LM, Luo J, Chang K, Wenthold RJ & Vicini S (2002). Relationship between availability of NMDA receptor subunits and their expression at the synapse. J Neurosci 22, 8902-8910.
44. Prybylowski K, Chang K, Sans N, Kan L, Vicini S & Wenthold RJ (2005). The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron 47, 845-857.
45. Rosenmund C, Feltz A & Westbrook GL (1995). Synaptic NMDA receptor channels have a low open probability. J Neurosci 15, 2788-2795.
46. Schreurs BG (2010). The effects of cholesterol on learning and memory. Neurosci Biobehav Rev 34, 1366-1379.
47. Simons K & Ikonen E (1997). Functional rafts in cell membranes. Nature 387, 569-572.
48. Soderberg M, Edlund C, Kristensson K & Dallner G (1990). Lipid compositions of different regions of the human brain during aging. J Neurochem 54, 415-423.
49. Sooksawate T & Simmonds MA (2001). Effects of membrane cholesterol on the sensitivity of the GABA(A) receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology 40, 178-184.
50. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ & Dingledine R (2010). Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62, 405-496.
51. Yeagle PL (1985). Cholesterol and the cell membrane. Biochimica et biophysica acta 822, 267-287.
52. Yuan H, Hansen KB, Vance KM, Ogden KK & Traynelis SF (2009). Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J Neurosci 29, 12045-12058.
53. Zacco A, Togo J, Spence K, Ellis A, Lloyd D, Furlong S & Piser T (2003). 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 23, 11104-11111.
54. Zervas M, Dobrenis K & Walkley SU (2001). Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations. J Neuropathol Exp Neurol 60, 49-64.